Sign in
Taking people in United StatesPhase 2

SONATA Dose Duration LIFU for OCD

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
20 people, planned
Started
15 Sept 2026
Expected to end
15 Sept 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • ATTN201 - Low Intensity Focused Ultrasound
Record updated
21 October 2026

Who can take part

Age
22 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age 22-80
  • Meet DSM-V criteria for OCD ≥ 1 year with a Y-BOCS score ≥ 16
  • Must be on the same stable dose(s) of OCD medication for at least 4 weeks prior to screening and throughout the course of the study

Who cannot take part

  • Co-morbid psychiatric disorder other than depression or anxiety disorder
  • History of neurological condition
  • Active suicidal risk (defined by C-SSRS)
  • Pregnant or breastfeeding, or planning to become pregnant during the study period

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 22 and 80 years old?

This trial is currently available in United States.

  • University of PennsylvaniaPhiladelphia, United StatesContact: Rishi SureshTaking people

About the trial

What the trial wants to find out

This study is testing a new, non-invasive brain stimulation approach for adults with Obsessive Compulsive Disorder (OCD). Researchers are evaluating the safety, tolerability, and target engagement of low-intensity focused ultrasound (LIFU) directed at a brain region called the subthalamic nucleus (STN). The ultrasound is delivered using a wearable device called ATTN201 (developed by Attune Neurosciences).

The 2 groups in the trial

  • Active StimulationTreatment being tested

    Participants receive low intensity focused ultrasound stimulation

    Treatment: ATTN201 - Low Intensity Focused Ultrasound

  • Sham StimulationSham treatment, for comparison

    Participants received unfocused ultrasound, which mimic the auditory and peripheral sensations of active stimulation without delivering meaningful pressure to the brain target

    Treatment: ATTN201 - Low Intensity Focused Ultrasound

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Subcortical OCD Neuromodulation With Acoustic Therapy - Dose Duration Optimization
Criteria questions
Built from NCT07887633, who can take part
Record updated
21 October 2026